Harlan F. Weisman - 10 Mar 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Mar 2023
Net transactions value
+$131,835
Form type
4
Filing time
13 Mar 2023, 08:00:20 UTC
Previous filing
19 Dec 2022
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Purchase $131,835 +150,000 +232% $0.8789 214,615 10 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were purchased in the open market in one transaction at the price of $0.8789.